<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Tue, 10 Mar 2026 03:20:39 -0400--><rss version="2.0">
    <channel>
        <title>LENZ Therapeutics, Inc. (LENZ) Press Releases</title>
        <link>https://ir.lenz-tx.com/news-events/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_8635510463fa1e52d68f761be7047ea9/lenztx/files/theme/images/logo-sm.png</url>
                <title>LENZ Therapeutics, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[LENZ Therapeutics to Present at Upcoming Investor Conferences]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.lenz-tx.com/news-events/press-releases/detail/49/lenz-therapeutics-to-present-at-upcoming-investor-conferences</link>
                <pubDate>Mon, 23 Feb 26 08:00:00 -0500</pubDate>
                <guid>https://ir.lenz-tx.com/news-events/press-releases/detail/49/lenz-therapeutics-to-present-at-upcoming-investor-conferences</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[LENZ Therapeutics and Sarah Jessica Parker announce the launch of “Make it VIZZable”, the VIZZ consumer campaign]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.lenz-tx.com/news-events/press-releases/detail/48/lenz-therapeutics-and-sarah-jessica-parker-announce-the-launch-of-make-it-vizzable-the-vizz-consumer-campaign</link>
                <pubDate>Wed, 14 Jan 26 08:30:00 -0500</pubDate>
                <guid>https://ir.lenz-tx.com/news-events/press-releases/detail/48/lenz-therapeutics-and-sarah-jessica-parker-announce-the-launch-of-make-it-vizzable-the-vizz-consumer-campaign</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[LENZ Therapeutics Reports Fourth Quarter 2025 Preliminary Unaudited Financial Results and Recent Corporate Updates]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.lenz-tx.com/news-events/press-releases/detail/47/lenz-therapeutics-reports-fourth-quarter-2025-preliminary-unaudited-financial-results-and-recent-corporate-updates</link>
                <pubDate>Wed, 07 Jan 26 17:08:00 -0500</pubDate>
                <guid>https://ir.lenz-tx.com/news-events/press-releases/detail/47/lenz-therapeutics-reports-fourth-quarter-2025-preliminary-unaudited-financial-results-and-recent-corporate-updates</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[LENZ Therapeutics and Lunatus Announce Exclusive Commercialization Partnership for VIZZ™ in the Middle East]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.lenz-tx.com/news-events/press-releases/detail/46/lenz-therapeutics-and-lunatus-announce-exclusive-commercialization-partnership-for-vizzin-the-middle-east</link>
                <pubDate>Mon, 05 Jan 26 08:00:00 -0500</pubDate>
                <guid>https://ir.lenz-tx.com/news-events/press-releases/detail/46/lenz-therapeutics-and-lunatus-announce-exclusive-commercialization-partnership-for-vizzin-the-middle-east</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[LENZ Therapeutics Announces MFDS Submission of New Drug Application for LNZ100 (VIZZ™) in South Korea for the Treatment of Presbyopia]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.lenz-tx.com/news-events/press-releases/detail/45/lenz-therapeutics-announces-mfds-submission-of-new-drug-application-for-lnz100-vizz-in-south-korea-for-the-treatment-of-presbyopia</link>
                <pubDate>Mon, 01 Dec 25 08:30:00 -0500</pubDate>
                <guid>https://ir.lenz-tx.com/news-events/press-releases/detail/45/lenz-therapeutics-announces-mfds-submission-of-new-drug-application-for-lnz100-vizz-in-south-korea-for-the-treatment-of-presbyopia</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[LENZ Therapeutics to Present at Upcoming Investor Conferences]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.lenz-tx.com/news-events/press-releases/detail/44/lenz-therapeutics-to-present-at-upcoming-investor-conferences</link>
                <pubDate>Tue, 25 Nov 25 16:05:00 -0500</pubDate>
                <guid>https://ir.lenz-tx.com/news-events/press-releases/detail/44/lenz-therapeutics-to-present-at-upcoming-investor-conferences</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.lenz-tx.com/news-events/press-releases/detail/43/lenz-therapeutics-reports-third-quarter-2025-financial-results-and-recent-corporate-highlights</link>
                <pubDate>Wed, 05 Nov 25 08:00:00 -0500</pubDate>
                <guid>https://ir.lenz-tx.com/news-events/press-releases/detail/43/lenz-therapeutics-reports-third-quarter-2025-financial-results-and-recent-corporate-highlights</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[LENZ Therapeutics to Report Third Quarter 2025 Financial Results and Recent Corporate Highlights on November 5, 2025]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.lenz-tx.com/news-events/press-releases/detail/42/lenz-therapeutics-to-report-third-quarter-2025-financial-results-and-recent-corporate-highlights-on-november-5-2025</link>
                <pubDate>Wed, 29 Oct 25 08:00:00 -0400</pubDate>
                <guid>https://ir.lenz-tx.com/news-events/press-releases/detail/42/lenz-therapeutics-to-report-third-quarter-2025-financial-results-and-recent-corporate-highlights-on-november-5-2025</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.lenz-tx.com/news-events/press-releases/detail/41/lenz-therapeutics-announces-commercial-product-availability-of-vizzin-the-united-states</link>
                <pubDate>Tue, 30 Sep 25 08:00:00 -0400</pubDate>
                <guid>https://ir.lenz-tx.com/news-events/press-releases/detail/41/lenz-therapeutics-announces-commercial-product-availability-of-vizzin-the-united-states</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[LENZ Therapeutics to Present at Upcoming Investor and Medical Conferences]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.lenz-tx.com/news-events/press-releases/detail/40/lenz-therapeutics-to-present-at-upcoming-investor-and-medical-conferences</link>
                <pubDate>Mon, 25 Aug 25 08:00:00 -0400</pubDate>
                <guid>https://ir.lenz-tx.com/news-events/press-releases/detail/40/lenz-therapeutics-to-present-at-upcoming-investor-and-medical-conferences</guid>
                                                                            </item>
            </channel>
</rss>